| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
P4HTM, also known as HIF prolyl hydroxylase 4, represents a distinctive member of the prolyl hydroxylase family that regulates hypoxia-inducible factor stability. Unlike its cytoplasmic counterparts, P4HTM contains a transmembrane domain that localizes it to the endoplasmic reticulum, positioning it uniquely within cellular oxygen-sensing pathways. This enzyme plays important roles in cardiovascular research, where understanding hypoxia response mechanisms remains central to investigating ischemic conditions and tissue adaptation.
This recombinant monoclonal antibody, clone 1B12, offers researchers the reproducibility essential for longitudinal studies and multi-site collaborations. Developed through recombinant technology using a synthesized peptide from human P4HTM protein, it provides sequence-defined specificity with consistent performance across production lots, eliminating the variability that can complicate experimental interpretation.
Validation across multiple platforms demonstrates this antibody's versatility in your workflow. Western blot analysis confirms detection in diverse human cell lines including U-251MG glioblastoma, HT-29 colorectal adenocarcinoma, A549 lung carcinoma, MCF-7 breast cancer, HepG2 hepatocellular carcinoma, and THP-1 monocytic cells, with an observed band at approximately 55 kDa. The slight difference from the predicted 57 kDa molecular weight likely reflects post-translational processing or conformational factors common to membrane-associated proteins. Immunohistochemistry validation in human placenta tissue using citrate buffer antigen retrieval demonstrates clear staining patterns, while flow cytometry analysis in PC-3 prostate cancer cells shows distinct positive population shifts compared to isotype controls.
Whether investigating oxygen-sensing mechanisms in cardiovascular disease models or characterizing P4HTM expression across tissue types, this antibody provides the technical foundation for reliable, reproducible results in your hypoxia-related research.
Email: support@cusabio.com
Distributors Worldwide